HECTD1 and breast cancer: Furthermore, HECTD1 has been shown to promote ubiquitylation-dependent degradation of ACF7 and that HECTD1 depletion in T47D breast cancer cells leads to increased ACF7 protein levels, enhanced epithelial–mesenchymal transition and promotes tumour growth, survival and metastasis (36).